B. Chabrol

11.1k total citations
235 papers, 3.9k citations indexed

About

B. Chabrol is a scholar working on Molecular Biology, Clinical Biochemistry and Psychiatry and Mental health. According to data from OpenAlex, B. Chabrol has authored 235 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Molecular Biology, 50 papers in Clinical Biochemistry and 43 papers in Psychiatry and Mental health. Recurrent topics in B. Chabrol's work include Metabolism and Genetic Disorders (49 papers), Mitochondrial Function and Pathology (28 papers) and Lysosomal Storage Disorders Research (17 papers). B. Chabrol is often cited by papers focused on Metabolism and Genetic Disorders (49 papers), Mitochondrial Function and Pathology (28 papers) and Lysosomal Storage Disorders Research (17 papers). B. Chabrol collaborates with scholars based in France, United States and Italy. B. Chabrol's co-authors include Mathieu Milh, Laurent Villard, Véronique Paquis‐Flucklinger, Sylvie Bannwarth, Cécile Rouzier, Annabelle Chaussenot, Aline Cano, Isabelle Desguerre, Pierre Cacciagli and Julien Mancini and has published in prestigious journals such as Brain, Neurology and PEDIATRICS.

In The Last Decade

B. Chabrol

218 papers receiving 3.8k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
B. Chabrol 1.6k 701 683 504 480 235 3.9k
Mariko Y. Momoi 1.9k 1.1× 629 0.9× 332 0.5× 244 0.5× 352 0.7× 202 4.0k
Michèl A.A.P. Willemsen 2.8k 1.7× 1.3k 1.8× 1.2k 1.7× 734 1.5× 583 1.2× 199 5.7k
Helena Pihko 2.6k 1.6× 480 0.7× 1.2k 1.8× 387 0.8× 723 1.5× 115 4.5k
Isabelle Desguerre 3.6k 2.2× 1.2k 1.8× 895 1.3× 613 1.2× 665 1.4× 212 7.1k
Dimitrios Zafeiriou 991 0.6× 510 0.7× 282 0.4× 577 1.1× 573 1.2× 171 3.3k
Florian Eichler 2.2k 1.4× 273 0.4× 447 0.7× 1.0k 2.0× 255 0.5× 127 4.0k
Mårten Kyllerman 1.2k 0.7× 759 1.1× 517 0.8× 190 0.4× 1.0k 2.1× 88 3.1k
Kazuhiro Haginoya 1.2k 0.8× 417 0.6× 199 0.3× 287 0.6× 453 0.9× 159 2.7k
Dorit Lev 2.0k 1.2× 1.0k 1.5× 441 0.6× 164 0.3× 1.6k 3.4× 188 4.9k
G Ponsot 1.5k 0.9× 458 0.7× 501 0.7× 219 0.4× 708 1.5× 147 3.8k

Countries citing papers authored by B. Chabrol

Since Specialization
Citations

This map shows the geographic impact of B. Chabrol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Chabrol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Chabrol more than expected).

Fields of papers citing papers by B. Chabrol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Chabrol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Chabrol. The network helps show where B. Chabrol may publish in the future.

Co-authorship network of co-authors of B. Chabrol

This figure shows the co-authorship network connecting the top 25 collaborators of B. Chabrol. A scholar is included among the top collaborators of B. Chabrol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Chabrol. B. Chabrol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Feillet, François, Jean‐Baptiste Arnoux, Alberto Burlina, et al.. (2024). Long‐term safety of sapropterin in paediatric and adult individuals with phenylalanine hydroxylase deficiency: Final results of the Kuvan® Adult Maternal Paediatric European Registry multinational observational study. Journal of Inherited Metabolic Disease. 48(1). e12796–e12796. 1 indexed citations
2.
Coz, Pierre Le, et al.. (2024). Continuous Deep Sedation Until Death of Children at the End of Life: French Physicians' Opinions. Journal of Palliative Medicine. 27(4). 451–463.
3.
Arnoux, Armelle, Anaïs Brassier, Samia Pichard, et al.. (2022). Transition from child to adult health care for patients with lysosomal storage diseases in France: current status and priorities—the TENALYS study, a patient perspective survey. Orphanet Journal of Rare Diseases. 17(1). 68–68. 8 indexed citations
4.
Boyer, Anthony, R. Bellance, Martin Krahn, et al.. (2019). Identification of novel pathogenic copy number variations in Charcot-Marie-Tooth disease. Journal of Human Genetics. 65(3). 313–323. 7 indexed citations
5.
Chabrol, B., et al.. (2019). Transition from paediatric to adult care in adolescents with neurological diseases and handicap. Revue Neurologique. 176(1-2). 37–42. 5 indexed citations
6.
Bernardor, Julie, H. Haas, Michel R. Popoff, et al.. (2018). Infant botulism: Two case reports and electroneuromyogram findings. Archives de Pédiatrie. 25(5). 340–343. 7 indexed citations
7.
8.
Boulay, C., M. Jacquemier, Vincent Pomero, et al.. (2015). Planovalgus foot deformity in cerebral palsy corrected by botulinum toxin injection in the peroneus longus: Clinical and radiological evaluations in young children. Annals of Physical and Rehabilitation Medicine. 58(6). 316–321. 9 indexed citations
9.
Chabrol, B., Catherine Caillaud, & Berge A. Minassian. (2013). Neuronal ceroid lipofuscinoses. Handbook of clinical neurology. 113. 1701–1706. 14 indexed citations
10.
Chen, Jian‐Min, Rafaëlle Bernard, Bernard de Massy, et al.. (2013). Dissecting the Structure and Mechanism of a Complex Duplication-Triplication Rearrangement in theDMDGene. Human Mutation. 34(8). 1080–1084. 23 indexed citations
11.
Héron, Bénédicte, Vassili Valayannopoulos, Julien Baruteau, et al.. (2012). Miglustat therapy in the French cohort of paediatric patients with Niemann-Pick disease type C. Orphanet Journal of Rare Diseases. 7(1). 36–36. 64 indexed citations
12.
Héron, Bénédicte, Yann Mikaeloff, Roseline Froissart, et al.. (2010). Incidence and natural history of mucopolysaccharidosis type III in France and comparison with United Kingdom and Greece. American Journal of Medical Genetics Part A. 155(1). 58–68. 128 indexed citations
13.
Chabrol, B., Chanita Hughes Halbert, Mathieu Milh, & Julien Mancini. (2009). Handicap : définitions et classifications. Archives de Pédiatrie. 16(6). 912–914. 3 indexed citations
14.
Giurgea, Irina, Chantal Missirian, Pierre Cacciagli, et al.. (2008). TCF4Deletions in Pitt-Hopkins Syndrome. Human Mutation. 29(11). E242–E251. 45 indexed citations
15.
Chabrol, B., Nadine Girard, Karine Nguyen, et al.. (2005). Delineation of the clinical phenotype associated with OPHN1 mutations based on the clinical and neuropsychological evaluation of three families. American Journal of Medical Genetics Part A. 138A(4). 314–317. 26 indexed citations
16.
Barois, A, M. Mayer, Isabelle Desguerre, et al.. (2005). Amyotrophie spinale infantile Étude multicentrique prospective et longitudinale de 168 cas suivis 4 ans. Bulletin de l Académie Nationale de Médecine. 189(6). 1181–1199. 20 indexed citations
17.
Viola, Angèle, B. Chabrol, François Nicoli, et al.. (2002). Magnetic Resonance Spectroscopy Study of Glycine Pathways in Nonketotic Hyperglycinemia. Pediatric Research. 52(2). 292–300. 36 indexed citations
18.
Serratrice, J., et al.. (2000). [Pseudometabolic distrophinopathy without immunohistochemical anomaly].. PubMed. 156(2). 175–8. 2 indexed citations
19.
Salvan, Anne-Marie, B. Chabrol, Sylvie Lamoureux, et al.. (1999). In vivo brain proton MR spectroscopy in a case of molybdenum cofactor deficiency. Pediatric Radiology. 29(11). 846–848. 7 indexed citations
20.
Long, Di, et al.. (1991). [Postoperative analgesia for nephrectomy].. PubMed. 39(8). 533–6. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mariko Y. Momoi Breakdown of academic impact, for papers by Michèl A.A.P. Willemsen Breakdown of academic impact, for papers by Helena Pihko Breakdown of academic impact, for papers by Isabelle Desguerre Breakdown of academic impact, for papers by Dimitrios Zafeiriou Breakdown of academic impact, for papers by Florian Eichler Breakdown of academic impact, for papers by Mårten Kyllerman Breakdown of academic impact, for papers by Kazuhiro Haginoya Breakdown of academic impact, for papers by Dorit Lev Breakdown of academic impact, for papers by G Ponsot
Rankless by CCL
2026